274 related articles for article (PubMed ID: 34608073)
1. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension.
Song J; Tang J; Zhang Z; Liu Y; Zhong J
Chin Med J (Engl); 2022 May; 135(9):1019-1026. PubMed ID: 34608073
[TBL] [Abstract][Full Text] [Related]
2. The Elabela-APJ axis: a promising therapeutic target for heart failure.
Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
[TBL] [Abstract][Full Text] [Related]
3. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
[TBL] [Abstract][Full Text] [Related]
4. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
Liu Y; Wang L; Shi H
Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
[TBL] [Abstract][Full Text] [Related]
5. [Research Progress on Role and Mechanism of Elabela in Organ Fibrosis].
Zhang Y; Luo PT; Li XY; Cui WP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):278-282. PubMed ID: 33966710
[TBL] [Abstract][Full Text] [Related]
6. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K; Sato T; Imai Y; Yamaguchi T
Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
[TBL] [Abstract][Full Text] [Related]
7. Elabela-apelin-12, 17, 36/APJ system promotes platelet aggregation and thrombosis via activating the PANX1-P2X7 signaling pathway.
Chen Z; Luo X; Liu M; Jiang J; Li Y; Huang Z; Wang L; Cao J; He L; Huang S; Hu H; Li L; Chen L
J Cell Biochem; 2023 Apr; 124(4):586-605. PubMed ID: 36855998
[TBL] [Abstract][Full Text] [Related]
8. The apelin/APJ system in the regulation of vascular tone: friend or foe?
Rikitake Y
J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
[TBL] [Abstract][Full Text] [Related]
9. Elabela Protects Spontaneously Hypertensive Rats From Hypertension and Cardiorenal Dysfunctions Exacerbated by Dietary High-Salt Intake.
Sainsily X; Coquerel D; Giguère H; Dumont L; Tran K; Noll C; Ionescu AL; Côté J; Longpré JM; Carpentier A; Marsault É; Lesur O; Sarret P; Auger-Messier M
Front Pharmacol; 2021; 12():709467. PubMed ID: 34385922
[No Abstract] [Full Text] [Related]
10. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
11. Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system.
Liu W; Yan J; Pan W; Tang M
Ann Transl Med; 2020 Mar; 8(5):243. PubMed ID: 32309390
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of apelin and Elabela in cardiovascular disease.
Gao S; Chen H
Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
[TBL] [Abstract][Full Text] [Related]
13. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
Sato T; Kuba K
Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
[TBL] [Abstract][Full Text] [Related]
14. Elabela Peptide: An Emerging Target in Therapeutics.
Sharma M; Prabhavalkar KS; Bhatt LK
Curr Drug Targets; 2022; 23(14):1304-1318. PubMed ID: 36029072
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target.
Xu C
Vascul Pharmacol; 2023 Aug; 151():107193. PubMed ID: 37433415
[TBL] [Abstract][Full Text] [Related]
16. The apelinergic-axis in human preeclamptic pregnancies: A systematic review.
Georgiadou D; Afink GB; van Dijk M
Pregnancy Hypertens; 2019 Jul; 17():148-157. PubMed ID: 31487633
[TBL] [Abstract][Full Text] [Related]
17. A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension.
Rozwadowski J; Borodzicz-Jażdżyk S; Czarzasta K; Cudnoch-Jędrzejewska A
Med Sci Monit; 2022 Dec; 28():e938112. PubMed ID: 36523134
[TBL] [Abstract][Full Text] [Related]
18. Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling.
Zhang Z; Tang J; Song J; Xie M; Liu Y; Dong Z; Liu X; Li X; Zhang M; Chen Y; Shi H; Zhong J
Free Radic Biol Med; 2022 Mar; 181():130-142. PubMed ID: 35122997
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling.
Song J; Zhang Z; Dong Z; Liu X; Liu Y; Li X; Xu Y; Guo Y; Wang N; Zhang M; Chen Y; Jin H; Zhong J
J Cardiovasc Transl Res; 2022 Jun; 15(3):535-547. PubMed ID: 35174434
[TBL] [Abstract][Full Text] [Related]
20. Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
Xu J; Chen L; Jiang Z; Li L
J Cell Physiol; 2018 Sep; 233(9):6472-6482. PubMed ID: 29350399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
